Information
Backnumber
Back Number of 2019
-
23 Dec.
TOWA PHARMACEUTICAL CO., LTD. reaches an agreement with ESTEVE to acquire ESTEVE's generic division, Pensa Investments
-
23 Dec.
Acquisition of Generic Drug Business from EsteveGroup (Spain)
-
11 Nov.
Updated IR Calendar
-
11 Nov.
FY2019(2nd quarter) Supplementary Material of Financial Results
-
23 Oct.
Updated Corporate Governance
-
1 Oct.
Updated Corporate Data
-
9 Aug.
FY2019(1st quarter) Supplementary Material of Financial Results
-
1 Jun.
Notice of the 63rd Ordinary General Meeting of Shareholders
-
14 May
FY2018 Supplementary Material of Financial Results
-
14 May
Revised Mid-term Business Plan FY2018-FY2020